Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 18366 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 54257 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 59452 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 70651 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 71520 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 73605 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 73815 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 79113 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 81139 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 81684 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 87079 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 87957 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 89773 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 107469 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 108048 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 109155 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 117163 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 119085 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 123607 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 139800 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 143467 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 147127 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 149582 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 156553 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 164961 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (2M-H)- | 218958 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 118083 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 344689 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 385964 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 421670 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 436097 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 443075 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 448817 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 466472 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 468773 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 472822 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 493172 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 501402 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 505350 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 569956 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 579198 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 587575 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 610483 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 615618 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 636394 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 694723 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 707816 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 715309 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 715493 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 770311 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 827278 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | TRYPTOPHAN (M-H)- | 989841 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 19600000 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 19900000 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 20300000 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 20800000 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 20900000 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 21000000 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 21000000 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 21100000 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 22300000 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 22700000 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 22800000 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 23100000 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 23500000 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 23900000 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 24600000 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 25000000 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 25100000 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 25400000 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 26000000 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 26400000 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 27500000 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 28200000 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 28400000 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 28400000 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 29700000 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+H)+ | 30400000 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 534764 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 564718 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 598176 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 602494 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 611406 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 611973 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 616261 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 618253 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 629890 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 630894 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 632655 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 655000 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 667510 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 673401 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 674433 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 682629 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 711679 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 721312 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 729132 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 732299 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 753801 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 755196 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 787735 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 795953 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 826939 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | TRYPTOPHAN (M+NA)+ | 879135 | Peak area normalized | female | Pre-diabetic | no neuropathy |